Bioplatforms Australia welcomes the recent announcement of the $185 million investment to fast-track treatments for rare and ‘untreatable’ cancers.
Bioplatforms Australia is seeking innovative ideas from current and potential future partners to identify opportunities to deepen and enhance the overall capability and capacity of its network.
The Bioplatforms Australia Plant Pathogen ‘Omics Initiative is now seeking partners to nominate and lead projects that will generate important genomic data resources for priority plant pathogen species.
The Woylie reference genome, and subsequent population genetic data, were used to inform the translocations of 54 Woylies into Mallee Cliffs National Park in NSW.
Since 2004, NCRIS has enabled a wealth of research excellence, making it both headline worthy and a critical pillar of the Australian economy. Leading economists agree.
Bioplatforms is committed to supporting the Australian life sciences community through a diverse access program, provision of targeted infrastructure requirements, and making integrated capability available to initiatives of breadth, scale and complexity in a way that is not readily achievable through other mechanisms.
In an Australian first, our national research infrastructures are creating a new digital atlas to allow researchers to easily discover and work with genomic data.
We are very excited to announce the completion of the NSW waratah (Telopea speciosissima) genome from our Genomics for Australian Plants (GAP) Initiative led by researchers from the Royal Botanic Gardens and Domain Trust, Sydney and the University of New South Wales, Sydney.